A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer.
Liang E, Beshara M, Sheng H, Huang XW, Roh JM, Laurent CA, Lee C, Delmerico J, Tang L, Lo JC, Hong CC, Ambrosone CB, Kushi LH, Kwan ML, Yao S.
Liang E, et al. Among authors: ambrosone cb.
Breast Cancer Res Treat. 2024 Nov;208(2):349-358. doi: 10.1007/s10549-024-07423-6. Epub 2024 Jul 8.
Breast Cancer Res Treat. 2024.
PMID: 38976164